US authorities have decided to impose draconian restrictions on sales of electronic cigarettes to stop the "epidemic" among young people, who are undisputedly attracted by this taste-tasting product.
The US Food and Drug Administration (FDA) announced today that it is offering a ban on the sale of e-flavored cigarettes online. These will only be available in shops, closed spaces and accessible to minors.
On the other hand, it is exempt from mint and menthol in the taste of electronic cigarettes, which are popular among adults and may be used to stop smoking.
The agency also plans to ban sales of cigarettes, menthol and cigars, noting that "menthol is used to disguise the repulsive aspects of smoke that drive the child from smoking."
Prior to its entry into force, these proposals must be submitted for public consultation until June.
The number of studies increased by 78% in US high schools from 2017 to 2018, and 48% in colleges, according to the latest data from a national survey.
"These figures are shocking to my conscience," Scott Gottlieb, head of the FDA, said in a statement. "This (consumption) increase must stop … I will not let a generation of children become addicted to nicotine through electronic cigarettes," he added.
Since 2016, the FDA regulates e-cigarettes, for example banned for sale for minors. But in the face of the mysterious rise in the number of viewers among young Americans, she decided to crack.
Altogether, 3.6 million students currently consume electronic cigarettes, 1.5 million more than in 2017, the FDA said Thursday.
More than a quarter of high school students volunteer regularly (at least 20 days in the past month). And 67.8% of them pour fragrance E-Cigarettes, figures rising sharply, she says.
– Future generation of smokers? –
"We will take all necessary steps to these trends and will not continue," insisted Scott Gottlieb, stressing the challenge: preventing young teens today from becoming adult smokers of tomorrow, then incurable patients.
Almost all adult smokers started when they were minors, he observes.
Cigarette is still the leading cause of disease and death can be prevented in the United States, and kills about 480,000 Americans every year. Some 16 million Americans also suffer from tobacco-related diseases.
Recently, Scott Gottlieb has called for eve- nage young people to "plague".
Health experts welcomed the proposals. "The ban on flavors, popular among teenagers, will certainly be an important step to curb the epidemic," said Patricia Folan, director of Tobacco Control Center, New York Hospital Network.
"Electronic cigarettes are known to be a gateway to cigarettes for teenagers and young adults," said Len Horowitz, a pulmonary specialist at Lenox Hill Hospital.
While many carcinogenic products, such as tar, are not found in electronic cigarettes, they contain nicotine, a product that is not related to cancer but causes addiction.
The FDA earlier ordered cigarette manufacturers a few weeks ago to find a way to prevent young people from buying their products.
The American tobacco group Altria (Marlboro, USA) has led by announcing October 25 that it will stop selling some of its most popular electronic cigarettes.
Was attacked from all sides, the number one electronic cigarette Joule, on Tuesday, announced the suspension of sales of its products even the most popular adolescents. He will stop selling most of his flavored flavors, especially those targeted by the FDA.
The manufacturer, whose products are very successful among young people, will also finish their promotion on social networks.
The San Francisco-based company, like many electronic cigarette manufacturers, says their products target older smokers who want to quit smoking.
But some of these products look like a USB stick which we cover filling with a liquid that contains nicotine flavored with all kinds of perfumes. Attractive for teenagers, they have established themselves among the youth of the world.
In Europe, the effectiveness of these cigarettes, supposed to help smokers to mend themselves, is questionable. In France, the Publique-Hôpitaux de Paris (AP-HP) has recently launched a nationwide study to evaluate the efficacy of this product compared to the drug.
On Wall Street there were shabby tobacco groups. Altria shares closed at 3.08%, British American Tobacco fell 3.64%.